ATC Group: A08AA05 Mazindol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A08AA05 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A08 Antiobesity preparations, excl. diet products
3 A08A Antiobesity preparations, excl. diet products
4 A08AA Centrally acting antiobesity products
5 A08AA05 Mazindol

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 1 mg

Active ingredients in A08AA05

Active Ingredient Description
Mazindol

Mazindol is a sympathomimetic amine for the treatment of obesity and Duchenne muscular dystrophy. Like other sympathomimetic appetite suppressants, mazindol is thought to act as a reuptake inhibitor of norepinephrine. In addition, it inhibits dopamine and serotonin reuptake. It stimulates the central nervous system, which increases heart rate and blood pressure, and decreases appetite.

Medicines in this ATC group

Ecuador (EC)

Japan (JP)

Mexico (MX)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.